Lucienne Ronco

Lucienne Ronco

Company: Fulcrum Therapeutics

Job title: Vice President Translational Medicine


Panel Discussion: Identification of Rare Disease Mechanisms Through Proteomics Analysis 11:00 am

Maximizing information gained from precious samples Linking genetics to actionable protein biomarkers Multi-omics and the future of understanding disease Opportunities presented by proteomic analysis specific to rare disease, current and future trendsRead more

day: Day One

Molecular and Imaging Biomarkers Applied to Clinical Trials in Facioscapulohumeral Muscular Dystrophy (FSHD) 1:30 pm

Development of a molecular endpoint of DUX4 activity in FSHD Using MRI as a tool to identify sites of active disease and as a marker of disease severity and progression Preparatory and Phase 1 studies designed to support biomarker selection and application in FSHD Phase 2 clinical trial design.Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.